Milestone Pharmaceuticals' Series A Round

Milestone Pharmaceuticals raised a round of funding on June 13, 2011.

Milestone, with headquarters in Montreal, Canada and a US subsidiary in Charlotte, NC, is a clinical stage drug development company focused on developing etripamil, a calcium channel blocker intended …

Articles about Milestone Pharmaceuticals' Series A Round: